MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study.

Front Pharmacol · 2025 · PMC12006192 · PMID 40255571

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although higher levels of miR-665 were more common in patients with high cytogenetic risk, this difference did not reach statistical significance in the present study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.